Cigna Group (NYSE:CI) Issues FY 2026 Earnings Guidance

Cigna Group (NYSE:CI) issued an update on its FY 2026 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 30.450- for the period, compared to the consensus EPS estimate of 30.510. The company issued revenue guidance of $280.0 billion-$280.0 billion, compared to the consensus revenue estimate of $287.2 billion.

Cigna Group Trading Up 1.1%

NYSE CI opened at $274.94 on Wednesday. The stock has a market cap of $72.65 billion, a P/E ratio of 11.38, a price-to-earnings-growth ratio of 0.93 and a beta of 0.31. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $315.47. The stock has a 50 day simple moving average of $279.78 and a two-hundred day simple moving average of $280.51. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76.

Cigna Group (NYSE:CI) last posted its earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.60 by $0.18. The firm had revenue of $70.04 billion for the quarter, compared to analysts’ expectations of $70.14 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The business’s revenue was up 6.7% compared to the same quarter last year. During the same period in the previous year, the firm earned $7.20 earnings per share. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, analysts forecast that Cigna Group will post 30.51 earnings per share for the current year.

Cigna Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th were given a dividend of $1.56 per share. The ex-dividend date was Tuesday, September 8th. This represents a $6.24 annualized dividend and a dividend yield of 2.3%. Cigna Group’s payout ratio is currently 25.82%.

Wall Street Analysts Forecast Growth

CI has been the subject of a number of research reports. Evercore began coverage on shares of Cigna Group in a research note on Wednesday, September 9th. They issued an “in-line” rating and a $290.00 price target for the company. Barclays increased their price target on shares of Cigna Group from $304.00 to $310.00 and gave the stock an “equal weight” rating in a research note on Friday, July 31st. Robert W. Baird set a $362.00 price objective on Cigna Group in a research note on Friday, July 31st. Mizuho upped their target price on shares of Cigna Group from $330.00 to $340.00 and gave the stock an “outperform” rating in a research note on Monday, June 8th. Finally, Wolfe Research reaffirmed an “outperform” rating and set a $315.00 price objective on shares of Cigna Group in a research report on Tuesday, June 16th. Fifteen investment analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $337.10.

Insider Activity at Cigna Group

In other Cigna Group news, insider Everett Neville sold 617 shares of Cigna Group stock in a transaction that occurred on Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total value of $175,258.85. Following the completion of the sale, the insider owned 5,053 shares of the company’s stock, valued at approximately $1,435,304.65. The trade was a 10.88% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole Jones sold 2,677 shares of the business’s stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $279.61, for a total transaction of $748,515.97. Following the sale, the insider owned 25,880 shares of the company’s stock, valued at approximately $7,236,306.80. This represents a 9.37% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 22,730 shares of company stock worth $6,293,359 in the last 90 days. 0.60% of the stock is currently owned by corporate insiders.

Cigna Group Company Profile

The Cigna Group (NYSE: CI) is a global health company that provides health care and related services to individuals, employers, government organizations and health plans. Its operations are primarily organized through Cigna Healthcare and Evernorth Health Services, which together address health coverage, pharmacy services, care delivery and benefit management.

Cigna Healthcare offers medical, dental, behavioral health, disability and other benefits, with a focus on employer-sponsored and individual health plans in the United States as well as international health services.